|
Size ($ in 1000's)
At 12/31/2023: $585,470 At 09/30/2023: $549,038
Combined Holding Report Includes:
GREAT POINT PARTNERS LLC JAY JEFFREY R Yehudai Ortav
Great Point Partners LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Great Point Partners LLC 13F filings.
Link to 13F filings: SEC filings
|
|
|
As of 12/31/2023, below is a summary of the Great Point Partners LLC top holdings by largest position size, as per the latest 13f filing made by Great Point Partners LLC.
In the Great Point Partners LLC-top-holdings-table below, each of the top holdings by name is presented in the first column, followed by the amount of shares
held by Great Point Partners LLC in that top holding, then the share count change between reporting periods, and finally the Great Point Partners LLC top holding position size
for that row.
Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size
($ in 1000's) |
ALPINE IMMUNE SCIENCES INC |
3,703,433 |
+624,800 |
$70,587 | ALPN | 3,703,433 | +624,800 | $70,587 | CYTOKINETICS INC |
500,000 |
-100,000 |
$41,745 | CYTK | 500,000 | -100,000 | $41,745 | UROGEN PHARMA LTD |
2,620,545 |
UNCH |
$39,308 | URGN | 2,620,545 | UNCH | $39,308 | PLIANT THERAPEUTICS INC |
1,823,184 |
+68,000 |
$33,018 | PLRX | 1,823,184 | +68,000 | $33,018 | ULTRAGENYX PHARMACEUTICAL IN |
648,000 |
-79,426 |
$30,987 | RARE | 648,000 | -79,426 | $30,987 | XENON PHARMACEUTICALS INC |
600,000 |
+99,999 |
$27,636 | XENE | 600,000 | +99,999 | $27,636 | RAPT THERAPEUTICS INC |
1,099,753 |
-358,317 |
$27,329 | RAPT | 1,099,753 | -358,317 | $27,329 | ALKERMES PLC |
875,044 |
UNCH |
$24,274 | ALKS | 875,044 | UNCH | $24,274 | AEROVATE THERAPEUTICS INC |
1,037,690 |
-53,543 |
$23,483 | AVTE | 1,037,690 | -53,543 | $23,483 | VAXCYTE INC |
360,000 |
-171,211 |
$22,608 | PCVX | 360,000 | -171,211 | $22,608 | EVOLUS INC |
2,000,000 |
-186,934 |
$21,060 | EOLS | 2,000,000 | -186,934 | $21,060 | ANAPTYSBIO INC |
976,981 |
+82,648 |
$20,927 | ANAB | 976,981 | +82,648 | $20,927 | IMMUNOCORE HLDGS PLC |
293,000 |
+2,083 |
$20,018 | IMCR | 293,000 | +2,083 | $20,018 | NEUROGENE INC |
994,229 |
+994,229 |
$19,268 | NGNE | 994,229 | +994,229 | $19,268 | AMICUS THERAPEUTICS INC |
1,280,500 |
+423,500 |
$18,170 | FOLD | 1,280,500 | +423,500 | $18,170 | TOURMALINE BIO INC |
672,885 |
+672,885 |
$17,616 | TRML | 672,885 | +672,885 | $17,616 | ABIVAX SA |
1,550,000 |
+1,550,000 |
$16,585 | ABVX | 1,550,000 | +1,550,000 | $16,585 | ZURA BIO LTD |
3,295,000 |
UNCH |
$15,388 | ZURA | 3,295,000 | UNCH | $15,388 | OPTINOSE INC |
8,839,939 |
UNCH |
$11,404 | OPTN | 8,839,939 | UNCH | $11,404 | APOGEE THERAPEUTICS INC |
400,000 |
UNCH |
$11,176 | APGE | 400,000 | UNCH | $11,176 | ARVINAS INC |
234,082 |
+234,082 |
$9,635 | ARVN | 234,082 | +234,082 | $9,635 | KARUNA THERAPEUTICS INC |
30,250 |
-30,250 |
$9,574 | KRTX | 30,250 | -30,250 | $9,574 | VISTAGEN THERAPEUTICS INC |
1,858,735 |
+1,858,735 |
$9,554 | VTGN | 1,858,735 | +1,858,735 | $9,554 | TERNS PHARMACEUTICALS INC |
1,309,975 |
+664,076 |
$8,502 | TERN | 1,309,975 | +664,076 | $8,502 | INTRA CELLULAR THERAPIES INC |
110,607 |
-114,393 |
$7,922 | ITCI | 110,607 | -114,393 | $7,922 | SAREPTA THERAPEUTICS INC |
80,000 |
+9,800 |
$7,714 | SRPT | 80,000 | -85,200 | $7,714 | INSMED INC |
225,912 |
-168,960 |
$7,001 | INSM | 225,912 | -168,960 | $7,001 | PUMA BIOTECHNOLOGY INC |
1,093,273 |
+1,093,273 |
$4,734 | PBYI | 1,093,273 | +1,093,273 | $4,734 | OCULAR THERAPEUTIX INC |
700,000 |
+700,000 |
$3,122 | OCUL | 700,000 | +700,000 | $3,122 | ARCELLX INC |
48,264 |
-239,236 |
$2,679 | ACLX | 48,264 | -239,236 | $2,679 | SPYRE THERAPEUTICS INC |
125,000 |
+125,000 |
$1,501 | AGLE | 125,000 | +125,000 | $1,501 | MERUS N V |
20,000 |
+20,000 |
$550 | MRUS | 20,000 | +20,000 | $550 | AXSOME THERAPEUTICS INC |
4,963 |
+4,963 |
$395 | AXSM | 4,963 | +4,963 | $395 |
See Full List: All Stocks Held By Great Point Partners LLC
— Including: Biggest new positions Biggest exits Biggest increased positions Biggest decreased positions
See Details: Top 10 Stocks Held By Great Point Partners LLC
|
|